Mensing Can't Keep Bristol-Myers' Plavix Suits Federal

Law360, New York (August 10, 2012, 7:59 PM EDT) -- Bristol-Myers Squibb Co. and McKesson Corp. on Friday lost a bid to keep eight lawsuits alleging harm from cardiovascular drug Plavix in California federal court, in part because a judge declined to extend the U.S. Supreme Court’s ruling in Pliva v. Mensing as far as requested.

In an attempt to preserve federal jurisdiction, Bristol-Myers said California-based McKesson shouldn’t be named in the case because, as a distributor, it lacked power to change drug labels and therefore was shielded by Mensing. That ruling last year said generic...
To view the full article, register now.